Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers' Case-Control Study

• Váldodahkkit: Gemma García-Lluch (Dahkki), Carmen Peña-Bautista (Dahkki), Lucrecia Moreno Royo (Dahkki), Miguel Baquero (Dahkki), Antonio José Cañada-Martínez (Dahkki), Consuelo Cháfer-Pericás (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2023-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

(1) Background: The role of antihypertensives in Alzheimer's Disease (AD) prevention is controversial. This case-control study aims to assess whether antihypertensive medication has a protective role by studying its association with amyloid and tau abnormal levels. Furthermore, it suggests a ho...